CWS
AdvisorShares Focused Equity ETF
The AdvisorShares Focused Equity ETF is an actively-managed ETF that aims to achieve long-term capital appreciation and outperform the S&P 500 Index by holding a focused group of US-listed stocks using proprietary models.
US
EQUITY
Active
MANAGEMENT STYLE
$ 176.5 M
ASSETS UNDER MGMT
84 bp
EXPENSES
Fund Basics
| Inception date | Sep 20, 2016 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Annually |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| MOODY'S CORP | 4.0 % |
| ABBOTT LABORATORIES | 4.0 % |
| SPROUTS FARMERS MARKET INC | 4.0 % |
| FACTSET RESEARCH SYSTEMS INC | 4.0 % |
| THERMO FISHER SCIENTIFIC INC | 4.0 % |
| CENCORA INC | 4.0 % |
| ADOBE SYSTEMS INC | 4.0 % |
| MCKESSON CORP | 4.0 % |
| INTERCONTINENTALEXCHANGE INC | 4.0 % |
| STRYKER CORP | 4.0 % |
Constituent Breakdown
| Number of holdings | 26 |
| Herfindahl-Hirschman Index | 389 |
| Wgt avg mkt cap (mns) | $67,447 |
| Large cap (>$10bn) | 78.9% |
| Mid cap ($2-10bn) | 15.8% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 94.7% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 94.7 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -5.8% | -1.1% | 0.8% | 8.4% | 7.7% | -- | -- | 10.4% |
| Dividend Yield | 0.0% | 0.3% | 0.4% | 0.4% | 0.4% | -- | -- | 0.6% |
| Total Returns | -5.8% | -0.8% | 1.3% | 8.8% | 8.1% | -- | -- | 11.0% | Ann. Volatility | 16.0% | 16.3% | 14.6% | 14.1% | 15.6% | -- | -- | 17.1% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 0.69 | 64% |
| MSCI EAFE | 0.67 | 53% |
| MSCI Emg Mkts | 0.51 | 39% |
Liquidity Measures
| Avg. volume (000) | 13 |
| ADV traded (mns) | $1 |
| Turnover | 0.5% |
| Avg. Bid/Ask (% of price) | 0.22% |
Technical Indicators
| 30d moving avg. (EMA) | $66.58 |
| Relative strength (RSI) | 53 |
| MACD/Signal | 0.21/-0.15 |
| Bollinger Bands (Upper/Lower) | $68.37/$63.17 |
| Short interest (% of AUM) | 0.5% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. CWS |
Expenses vs. CWS |
ALTAR Score™ vs. CWS |
|---|---|---|---|---|
| BEEZ | Honeytree U.S. Equity ETF | 14.7% | -20 bp | -1.3% |
| XLV | Health Care Select Sector SPDR | 12.9% | -76 bp | +1.8% |
| SEMG | Suncoast Select Growth ETF | 12.7% | -24 bp | -0.6% |
| QOWZ | Invesco Nasdaq Free Cash Flow Achievers ETF | 12.6% | -45 bp | -1.2% |
| IHI | iShares U.S. Medical Devices ETF | 11.9% | -44 bp | -0.4% |
| FHLC | Fidelity MSCI Health Care Index ETF | 11.5% | -76 bp | +0.5% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 11.5% | -44 bp | +1.7% |
| MDCP | VictoryShares THB Mid Cap ESG ETF | 11.2% | -29 bp | -0.3% |
| GDOC | Goldman Sachs Future Health Care Equity ETF | 11.0% | -9 bp | -4.0% |
| DVGR | DAC 3D Dividend Growth ETF | 10.9% | -19 bp | -0.2% |
Risk and Returns: CWS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/23/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
5.4%
ALTAR SCORE™
49th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,199 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. CWS's ALTAR Score™ is approximately 0.0 standard
deviations above the category average. This places CWS in the 49th percentile
among funds in the category.
Sell-Side Consensus
$82.93
PRICE TARGET
+21.4%
UPSIDE